Latest Regulatory Milestones News

Riversgold Limited has reported standout assay results from 31 drill holes at its Northern Zone Gold Project, including a spectacular 71 g/t gold intercept. The campaign expands the shallow gold mineralisation footprint, supporting imminent mining lease conversion and a funding agreement with MEGA Resources.

Nyrada has secured ethics approval to start its Phase IIa trial of Xolatryp in heart attack patients, with recruitment beginning in April 2026. The biotech also bolsters its cash position to AU$6.74 million and pursues new oncology indications.

Vysarn Limited's joint venture with Kariyarra Aboriginal Corporation has been shortlisted by Water Corporation to submit a formal proposal for supplying bulk water to Port Hedland, progressing key regulatory approvals for the Kariyarra Water Scheme.

Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.

Zeotech Limited has made significant progress on its Toondoon Kaolin Project, securing critical environmental approvals, advancing mine planning, and preparing for an initial kaolin shipment amid rising contractor cost pressures.

PainChek has secured a landmark agreement with Sabra Health Care REIT to deploy its AI-powered pain assessment across up to 20,000 beds in North America, marking a pivotal step in its US expansion.

Orpheus Uranium has secured key regulatory approvals for advanced exploration across multiple projects and raised $4.37 million, including a cornerstone investment from IsoEnergy, as it prepares for a busy 2026 drilling season.

Bayan Mining and Minerals has locked in a reverse circulation drill rig with Alaska Midnight Sun Drilling for its first-ever drilling at the Desert Star rare earth project in California, targeting up to 1,000 metres from June 2026. The fully permitted program aims to test high-grade surface mineralisation and geophysical targets near the Mountain Pass mine.

Jameson Resources has secured A$3 million through a discounted share placement to advance critical environmental approvals and Indigenous engagement for its Crown Mountain coal project in British Columbia, aiming to submit the final application by late 2026.

Magnetic Resources NL has lodged a draft Scheme Booklet with ASIC and ASX, marking a key step in its proposed acquisition by Genesis Minerals Limited. The booklet includes an independent expert’s report, with shareholder approval expected by mid-2026.

St Barbara has secured key environmental approvals to restart its Touquoy gold processing facility in Nova Scotia, targeting ore processing by the end of 2026. The project aims to produce 38,000 ounces of gold over 13 months, generating significant cash flow and local economic benefits.

Telix Pharmaceuticals has announced FDA acceptance of its resubmitted NDA for TLX101-Px (Pixclara®), a PET imaging agent for glioma, setting a PDUFA goal date of September 11, 2026. The agent addresses a significant unmet need in distinguishing recurrent glioma from treatment effects.